[en] BACKGROUND: It seems that sleep quality could impact the physiological process related to loss of muscle mass.
OBJECTIVES: We seek to compare subjective sleep quality of sarcopenic and non-sarcopenic subjects diagnosed according to 6 definitions.
DESIGN: Cross-sectional data used in this analysis were collected from the SarcoPhAge (Sarcopenia and Physical Impairment with Advancing Age) cohort, a prospective study aiming to assess clinical parameters linked to sarcopenia.
PARTICIPANTS: The present study was interested in communitydwelling older adults with and without sarcopenia. Measurements - A diagnosis of sarcopenia was established according to 6 definitions. Three assessments were carried out: an evaluation of lean mass, a measurement of muscle strength and an assessment of physical performance. In addition, to evaluate the parameters of subjective sleep, we used the Pittsburgh Sleep Quality Index (PSQI), a self-administered questionnaire evaluating 7 components of sleep architecture.
RESULTS: A total of 255 individuals aged 74.7±5.8 years were included. Based on the 6 different definitions, the prevalence of sarcopenia ranged from 5.9% to 32.5%. There was no significant difference between sarcopenic and non-sarcopenic subjects regarding most of the components of subjective sleep quality. However, the definition of Cruz-Jentoft et al. (2010) indicated that sarcopenic subjects had higher scores than non-sarcopenic subjects for two components: sleep latency and day-time dysfunction (p=0.03 and p=0.04, adjusted for confounders). Moreover, some parameters of sleep quality were correlated with components of sarcopenia.
CONCLUSIONS: Some properties of subjective sleep quality seem to be associated with sarcopenia and seem correlated with at least one of the three components of the condition.
Disciplines :
General & internal medicine
Author, co-author :
Locquet, Médéa ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique
Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Delandsheere, Laura ; Université de Liège - ULiège > Master sc. santé publ., à finalité
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Subjective sleep quality among sarcopenic and non-sarcopenic older adults - results from the SarcoPhAge Cohort.
Rosenberg IH. Sarcopenia: origins and clinical relevance. J. Nutr. 1997;127:990–991. DOI: 10.1093/jn/127.5.990S
Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 2006;61:1059–64. DOI: 10.1093/gerona/61.10.1059
Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 2012;23:1839–48. DOI: 10.1007/s00198-012-1913-1
Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998;147:755–63. DOI: 10.1093/oxfordjournals.aje.a009520
Delmonico MJ, Harris TB, Lee J-S, et al. Alternative Definitions of Sarcopenia, Lower Extremity Performance, and Functional Impairment with Aging in Older Men and Women. J. Am. Geriatr. Soc. 2007;55:769–74. DOI: 10.1111/j.1532-5415.2007.01140.x
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. Oxford University Press. 2010;39:412–23. DOI: 10.1093/ageing/afq034
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J. Am. Med. Dir. Assoc. 2011;12:249–56. DOI: 10.1016/j.jamda.2011.01.003
Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia With Limited Mobility: An International Consensus. J. Am. Med. Dir. Assoc. 2011;12:403–9. DOI: 10.1016/j.jamda.2011.04.014
Studenski SA, Peters KW, Alley DE, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. Journals Gerontol. Ser. A Biol. Sci. Med. Sci. 2014;69:547–58. DOI: 10.1093/gerona/glu010
Beaudart C, Reginster JY, Slomian J, et al. Estimation of sarcopenia prevalence using various assessment tools. Exp. Gerontol. 2015;61:31–7. DOI: 10.1016/j.exger.2014.11.014
Beaudart C, Reginster J-Y, Slomian J, Buckinx F, Locquet M, Bruyère O. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J. Musculoskelet. Neuronal Interact. 2014;14:425–31.
Dupuy C, Lauwers-Cances V, Guyonnet S, et al. Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS study. J. Cachexia. Sarcopenia Muscle. 2015.https://doi.org/wiley.com/10.1002/jcsm.12021.
Dodds RM, Roberts HC, Cooper C, Sayer AA. The Epidemiology of Sarcopenia. J. Clin. Densitom. Europe PMC Funders. 2015;18:461–6. DOI: 10.1016/j.jocd.2015.04.012
Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. Wright JM,editor. PLoS One. 2017;12:e0169548. DOI: 10.1371/journal.pone.0169548
Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve. 2002;25:17–25. DOI: 10.1002/mus.1215
Kamel HK, Maas D, Duthie EH. Role of hormones in the pathogenesis and management of sarcopenia. Drugs Aging. 2002;19:865–77. DOI: 10.2165/00002512-200219110-00004
Schaap LA, Pluij. SMF, Deeg DJH, Visser M. Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength. Am. J. Med. 2006;119:526e9–526e17. DOI: 10.1016/j.amjmed.2005.10.049
Crowley K. Sleep and Sleep Disorders in Older Adults. Neuropsychol. Rev. 2011;21:41–53. DOI: 10.1007/s11065-010-9154-6
Ancoli-Israel S, Cooke JR. Prevalence and Comorbidity of Insomnia and Effect on Functioning in Elderly Populations. J. Am. Geriatr. Soc. 2005;53:S264–71. DOI: 10.1111/j.1532-5415.2005.53392.x
Piovezan RD, Abucham J, do. Santos RVT, Mello MT, Tufik S, Poyares D. The impact of sleep on age-related sarcopenia: Possible connections and clinical implications. Ageing Res. Rev. 2015;23:210–20. DOI: 10.1016/j.arr.2015.07.003
Chien M-Y, Wang L-Y, Chen H-C. The Relationship of Sleep Duration with Obesity and Sarcopenia in Community-Dwelling Older Adults. Gerontology. 2015;61:399–406. DOI: 10.1159/000371847
Hu X, Jiang J, Wang H, Zhang L, Dong B, Yang M. Association between sleep duration and sarcopenia among community-dwelling older adults. Medicine (Baltimore). 2017;96:e6268. DOI: 10.1097/MD.0000000000006268
Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY. The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif. Tissue Int. 2017;100:229–34. DOI: 10.1007/s00223-016-0220-9
Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp. Gerontol. 2015;69:103–10. DOI: 10.1016/j.exger.2015.05.003
Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J. Am. Geriatr. Soc. 1992;40:922–35. DOI: 10.1111/j.1532-5415.1992.tb01992.x
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A. Biol. Sci. Med. Sci. 2001;56:M146–56. DOI: 10.1093/gerona/56.3.M146
Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40:423–9. DOI: 10.1093/ageing/afr051
Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J. Gerontol. A. Biol. Sci. Med. Sci. 2000;55:M221–31. DOI: 10.1093/gerona/55.4.M221
Blais FC, Gendron L, Mimeault V, Morin CM. Evaluation de l’insomnie: validation de trois questionnaires. L’ Encéphale. Elsevier Masson. 1997;23:447–53.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. DOI: 10.1016/0165-1781(89)90047-4
